1-5 of 5
Peter Buhl Jensen
Close
Save search
Follow your search
Access your saved searches in your account
Would you like to receive an alert when new items match your search?
Close Modal
Sort by
Journal Articles

A Phase 1 Pharmacokinetic and Pharmacodynamic Study of the Histone Deacetylase Inhibitor Belinostat in Patients with Advanced Solid Tumors

Free
Nicola L. Steele, Jane A. Plumb, Laura Vidal, Jette Tjørnelund, Poul Knoblauch, Annie Rasmussen, Chean Eng Ooi, Peter Buhl-Jensen, Robert Brown, T.R. Jeffry Evans, Johann S. DeBono
Journal: Clinical Cancer Research
Clin Cancer Res (2008) 14 (3): 804–810.
https://doi.org/10.1158/1078-0432.CCR-07-1786
Published: 01 February 2008
View articletitled, A Phase 1 Pharmacokinetic and Pharmacodynamic Study of the Histone Deacetylase Inhibitor Belinostat in Patients with Advanced Solid Tumors
Open the PDF for A Phase 1 Pharmacokinetic and Pharmacodynamic Study of the Histone Deacetylase Inhibitor Belinostat in Patients with Advanced Solid Tumors in another window
Journal Articles

Combining Etoposide and Dexrazoxane Synergizes with Radiotherapy and Improves Survival in Mice with Central Nervous System Tumors

Free
Kenneth Francis Hofland, Annemette Vinding Thougaard, Marielle Dejligbjerg, Lars H. Jensen, Paul E.G. Kristjansen, Pia Rengtved, Maxwell Sehested, Peter Buhl Jensen
Journal: Clinical Cancer Research
Clin Cancer Res (2005) 11 (18): 6722–6729.
https://doi.org/10.1158/1078-0432.CCR-05-0698
Published: 15 September 2005
View articletitled, Combining Etoposide and Dexrazoxane Synergizes with Radiotherapy and Improves Survival in Mice with Central Nervous System Tumors
Open the PDF for Combining Etoposide and Dexrazoxane Synergizes with Radiotherapy and Improves Survival in Mice with Central Nervous System Tumors in another window
Journal Articles

Dexrazoxane Protects against Myelosuppression from the DNA Cleavage–Enhancing Drugs Etoposide and Daunorubicin but not Doxorubicin

Free
Kenneth Francis Hofland, Annemette Vinding Thougaard, Maxwell Sehested, Peter Buhl Jensen
Journal: Clinical Cancer Research
Clin Cancer Res (2005) 11 (10): 3915–3924.
https://doi.org/10.1158/1078-0432.CCR-04-2343
Published: 16 May 2005
View articletitled, Dexrazoxane Protects against Myelosuppression from the DNA Cleavage–Enhancing Drugs Etoposide and Daunorubicin but not Doxorubicin
Open the PDF for Dexrazoxane Protects against Myelosuppression from the DNA Cleavage–Enhancing Drugs Etoposide and Daunorubicin but not Doxorubicin in another window
Journal Articles

Treatment of Anthracycline Extravasation with Dexrazoxane

Free
Seppo W. Langer, Maxwell Sehested, Peter Buhl Jensen
Journal: Clinical Cancer Research
Clin Cancer Res (2000) 6 (9): 3680–3686.
Published: 01 September 2000
View articletitled, Treatment of Anthracycline Extravasation with Dexrazoxane
Open the PDF for Treatment of Anthracycline Extravasation with Dexrazoxane in another window
Journal Articles

Inhibitors of Topoisomerase II as pH-dependent Modulators of Etoposide-mediated Cytotoxicity

Free
Seppo W. Langer, Günther Schmidt, Morten Sørensen, Maxwell Sehested, Peter Buhl Jensen
Journal: Clinical Cancer Research
Clin Cancer Res (1999) 5 (10): 2899–2907.
Published: 01 October 1999
View articletitled, Inhibitors of Topoisomerase II as pH-dependent Modulators of Etoposide-mediated Cytotoxicity
Open the PDF for Inhibitors of Topoisomerase II as pH-dependent Modulators of Etoposide-mediated Cytotoxicity in another window